Health Decisions, Inc. government contracts
$47.5M obligated across 13 federal awards. 5 are still running.
Who buys from Health Decisions, Inc.
| Agency | Awards | Obligated |
|---|---|---|
| National Institutes of Health | 13 | $47.5M |
What Health Decisions, Inc. sells
Its awards by NAICS code. Codes with live notices link to them.
| Industry | Awards | Obligated |
|---|---|---|
| NAICS 541712 NAICS 541712 | 5 | $26.8M |
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) NAICS 541715 | 8 | $20.8M |
Contracts ending soon
Awards that end in the next 18 months, soonest first. Expiring work is often recompeted.
| Award | Obligated | Start | End |
|---|---|---|---|
| STATISTICAL AND CLINICAL COORDINATING SERVICES FOR GROUPS C AND D OF CCN021 ENTITLED, "A STUDY TO EVALUATE THE PK AND PD OF IM OR SQ INJECTIONS OF LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION" National Institutes of Health · 75N94023F00002 | $2.3M | May 25, 2023 | Oct 21, 2026 |
| FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL National Institutes of Health · 75N94023F00003 | $2.2M | Sep 1, 2023 | Jul 31, 2027 |
| NICHD: R&D: COORDINATION, MONITORING, FOLLOW-UP, EVALUATION, AND COMPLETION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE National Institutes of Health · 75N94025F00001 | $1.2M | May 1, 2025 | Oct 31, 2027 |
| NICHD: R&D: SUPPORTING THE PHASE IIB CLINICAL TRIAL OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION: NON-SEVERABLE National Institutes of Health · 75N94025F00002 | $1.3M | Aug 1, 2025 | Mar 31, 2028 |
Largest awards
By total obligated value. Each links to its record on USAspending.gov.
Similar contractors
Companies winning under the same main NAICS code.
| Contractor | Awards | Obligated |
|---|---|---|
| Massachusetts Institute of Technology UEI SN5KKUDR9LY8 | 22 | $12B |
| California Institute of Technology UEI YC1YP79BFD19 | 86 | $8.7B |
| The Boeing Company UEI SML4NN2CT556 | 8 | $8.1B |
| Raytheon Company UEI VTEWM5QSE598 | 12 | $6.3B |
| Science Applications International Corporation UEI MMLKPW9JLX64 | 58 | $6.2B |
| The Aerospace Corporation UEI YA8LJBJCND19 | 26 | $4.4B |
Stop checking this page by hand
Matched, not listed
Describe your company once. Captivaq scores every new notice against your capabilities, locations, and set-asides.
Earlier than the RFP
Forecasts and sources sought notices surface months before the solicitation, while you can still shape the win.
A draft, not a link
For the bids worth pursuing, it reads the solicitation and drafts the response with citations back to the source.
Questions people ask
What is Health Decisions, Inc.'s UEI?
CMKQYLSLNJG1. The Unique Entity ID is the 12-character number SAM.gov assigns to every company that registers to do business with the federal government. It replaced the DUNS number in 2022.
How much has Health Decisions, Inc. won in federal contracts?
$47.5M obligated across 13 awards in Captivaq's records, most of it from National Institutes of Health. That covers contracts of $1M or more active since October 2023, so the full history is larger.
Which Health Decisions, Inc. contracts end soon?
4 awards end in the next 18 months, listed on this page. Expiring contracts are often recompeted, which is the opening for a competitor or a teaming partner.
Figures come from federal award records published on USAspending.gov: contracts of $1M or more active since October 2023, plus smaller awards tied to open opportunities. They are not a complete contract history; each award above links to its official record.
Captivaq is an independent service from Logesta Labs LLC and is not affiliated with or endorsed by the U.S. government or SAM.gov. The notice on the official source portal is the record that governs; confirm deadlines and amendments there.